4-碘-1-甲基吲唑 | 935661-15-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 中文名称: 4-碘-1-甲基吲唑
• 中文别名: 4-碘-1-甲基-1H-吲唑
• 英文名称: 4-iodo-1-methyl-1H-indazole
• 英文别名: 4-iodo-1-methylindazole
• CAS: 935661-15-7
• 化学式: C₈H₇IN₂
• 分子量: 258.061
• InChiKey: UAOIHDMXVVPOAZ-UHFFFAOYSA-N

物化性质

• 沸点：
  318.4±15.0 °C(Predicted)
• 密度：
  1.89±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-碘-1-甲基吲唑 、 1-[4-(tetramethyldioxaborolanyl)phenyl]-3-m-tolylurea 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride sodium carbonate 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 N-[4-(1-methyl-1H-indazol-4-yl)-phenyl]-N''-(3-methylphenyl)urea
  参考文献：
  名称：

  Discovery of N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor

  摘要：

  In our continued efforts to search for potent and novel receptor tyrosine kinase (RTK) inhibitors as potential anticancer agents, we discovered, through a structure-based design, that 3-aminoindazole could serve as an efficient hinge-binding template for kinase inhibitors. By incorporating an N,N'-diaryl urea moiety at the C4-position of 3-aminodazole, a series of RTK inhibitors were generated, which potently inhibited the tyrosine kinase activity of the vascular endothelial growth factor receptor and the platelet-derived growth factor receptor families. A number of compounds with potent oral activity were identified by utilizing an estradiol-induced mouse uterine edema model and an HT1080 human fibrosarcoma xenograft tumor model. In particular, compound 17p (ABT-869) was found to possess favorable pharmacokinetic profiles across different species and display significant tumor growth inhibition in multiple preclinical animal models.

  DOI：

  10.1021/jm061280h
• 作为产物：
  描述：

  2-氟-6-碘苯甲醛 、 甲基肼 反应 24.0h， 以48%的产率得到4-碘-1-甲基吲唑
  参考文献：
  名称：

  Discovery of N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N‘-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor

  摘要：

  In our continued efforts to search for potent and novel receptor tyrosine kinase (RTK) inhibitors as potential anticancer agents, we discovered, through a structure-based design, that 3-aminoindazole could serve as an efficient hinge-binding template for kinase inhibitors. By incorporating an N,N'-diaryl urea moiety at the C4-position of 3-aminodazole, a series of RTK inhibitors were generated, which potently inhibited the tyrosine kinase activity of the vascular endothelial growth factor receptor and the platelet-derived growth factor receptor families. A number of compounds with potent oral activity were identified by utilizing an estradiol-induced mouse uterine edema model and an HT1080 human fibrosarcoma xenograft tumor model. In particular, compound 17p (ABT-869) was found to possess favorable pharmacokinetic profiles across different species and display significant tumor growth inhibition in multiple preclinical animal models.

  DOI：

  10.1021/jm061280h

文献信息

• [EN] SUBSTITUTED ALKYNYLENE COMPOUNDS AS ANTICANCER AGENTS<br/>[FR] COMPOSÉS ALCYNYLÈNE SUBSTITUÉS EN TANT QU'AGENTS ANTICANCÉREUX
  申请人：AURIGENE DISCOVERY TECH LTD

  公开号：WO2019142126A1

  公开（公告）日：2019-07-25

  The present invention relates to substituted alkynylene compounds represented by compound of formula (I) pharmaceutically acceptable salts and stereoisomers thereof. The present invention further provides the methods of preparation of compound of formula (I) and therapeutic uses thereof as anti-cancer agents.

  本发明涉及代表为化合物(I)的取代炔基化合物，其药学上可接受的盐和立体异构体。本发明还提供了化合物(I)的制备方法以及作为抗癌药物的治疗用途。
• [EN] BENZENE RING-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF<br/>[FR] COMPOSÉ CONTENANT UN CYCLE BENZÉNIQUE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION<br/>[ZH] 含苯环的化合物、其制备方法及应用
  申请人：GUANGZHOU WELLHEALTH BIO PHARMACEUTICAL CO LTD

  公开号：WO2020011246A1

  公开（公告）日：2020-01-16

  一种含苯环的化合物、其制备方法及应用。具体提供了一种如式（I-0）所示化合物、其药学上可接受的盐、其溶剂合物、其代谢产物、其立体异构体、其互变异构体或其前药。该化合物可用作免疫调节剂，其呈现活性高、药效好、药物稳定、以及可与其它免疫调节剂进行联合用药等优点。
• Substituted Alkynylene Compounds As Anticancer Agents
  申请人：Aurigene Discovery Technologies Limited

  公开号：US20210379055A1

  公开（公告）日：2021-12-09

  The present invention relates to substituted alkynylene compounds represented by the compounds of formula (I), pharmaceutically acceptable salts and stereoisomers thereof. The present invention further provides the therapeutic uses of the compounds of formula (I) as anti-cancer agents.
• [EN] METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION<br/>[FR] MÉTHODES ET COMPOSÉS POUR LA RESTAURATION DE LA FONCTION DU P53 MUTANT
  申请人：PMV PHARMACEUTICALS INC

  公开号：WO2021231474A1

  公开（公告）日：2021-11-18

  Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods to recover wild-type function to p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.
• Simplifying Access to Targeted Protein Degraders via Nickel Electrocatalytic Cross‐Coupling
  作者：Philipp Neigenfind、Luca Massaro、Áron Péter、Andrew P. Degnan、Megan A. Emmanuel、Martins S. Oderinde、Chi He、David Peters、Tamara El‐Hayek Ewing、Yu Kawamata、Phil S. Baran

  DOI：10.1002/anie.202319856

  日期：2024.4.15

  C−C linked glutarimide‐containing structures with direct utility in the preparation of cereblon‐based degraders (PROTACs, CELMoDs) can be assessed in a single step from inexpensive, commercial α‐bromoglutarimide through a unique Brønsted‐acid assisted Ni‐electrocatalytic approach. The reaction tolerates a broad array of functional groups that are historically problematic and can be applied to the simplified synthesis of dozens of known compounds that have only been procured through laborious, wasteful, multi‐step sequences. The reaction is scalable in both batch and flow and features a trivial procedure wherein the most time‐consuming aspect of reaction setup is weighing out the starting materials.